Opinion: The rise of perimenopause misinformation
Stat News • 5/20/2026
Summary
The opinion piece discusses the rise of misinformation regarding perimenopause symptoms. Two experts share their insights on this topic in the “First Opinion Podcast.”
Advertisement
Lindy Score Breakdown (V4.2)
8h
Age
1
Sources
from cluster
5
Hours Since Seen
Final Score12/100
CategoryAntiLindy
StatusActive
Recency Multiplier93% (0.5^5/48)
Hero EligibleYes
Score BreakdownRisk 70
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: Breaking news - too recent to assess longevity
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
Opinion: I’m a heart transplant recipient. I’m haunted by ‘ghost approval’ for medication I need to survive
Stat News • 1 day ago
Opinion: Britain embraces a Massachusetts experiment on tobacco regulation — just as the state might roll it back
Stat News • 1 day ago
Opinion: How to restore credibility to the CDC’s vaccine advisory committee
Stat News • 2 days ago
Opinion: ‘Patient autonomy’ has nothing to do with childhood vaccine policies
Stat News • 2 days ago
STAT+: A new ranking of pharma companies by R&D performance
Stat News • 1 day ago
The latest on Ebola: A travel ban and an old vaccine
Stat News • 1 day ago
STAT+: Pharmalittle: We’re reading about biotech investors’ mood, a former FDA head’s confidence, and more
Stat News • Today
STAT+: The China question is tearing biotech apart
Stat News • 2 days ago
In Ebola outbreak, a number of Americans in the Congo believed to have had exposure to suspected cases
Stat News • 2 days ago
STAT+: Pharmalittle: We’re reading about U.S. biotech’s China problem, a Regeneron flop, and much more
Stat News • 2 days ago
